References
- Allinger NL. (1977). Conformational-analysis.130. MM2 – hydrocarbon force-field utilizing V1 and V2 torsional terms. J Am Chem Soc 99:8127–34
- Baker Z, Davison C, Smith P. (1950). The effect of podophyllotoxin, colchicines, urethane, and nitrogen mustard on the respiration of normal and suprarenalectomized rat lymphatic tissue. J Exp Med 92:113–19
- Chang H, Shyu KG, Lee CC, et al. (2003). GL331 inhibits HIF-1alpha expression in a lung cancer model. Biochem Biophys Res Commun 302:95–100
- Collier HO, Dinneen LC, Johnson CA, Schneider C. (1968). The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother 32:295–310
- Deraedt R, Jouquey S, Delevallee F, Flahaut M. (1980). Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur J Pharmacol 61:17–24
- Dewick PM, Jackson DE. (1981). Cytotoxic lignans from podophyllum, and the nomenclature of aryltetralin lignans. Phytochemistry 20:2277–80
- Dumontet C, Jordan MA. (2010). Microtubule-binding agents: A dynamic field of cancer therapeutics. Nat Rev Drug Discov 9:790–803
- Guay J, Bateman K, Gordon R, et al. (2004). Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem 279:24866–72
- Haasnoot CAG, Deleeuw F, Altona C. (1980). The relationship between proton-proton NMR coupling-constants and substituent electronegativities. 1: an empirical generalization of the Karplus equation. Tetrahedron 36:2783–92
- Hande KR. (1998). Etoposide: Four decades of development of a topoisomerase II inhibitor. Eur J Cancer 34:1514–21
- Hartwell JL, Schrecker AW. (1958). The chemistry of podophyllum. Fortschr Chem Org Naturst 15:83–166
- Jackson JK, Higo T, Hunter WL, Burt HM. (2008). Topoisomerase inhibitors as anti-arthritic agents. Inflamm Res 57:126–34
- Jordan A, Hadfield JA, Lawrence NJ, McGown AT. (1998). Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev 18:259–96
- Kluza J, Mazinghien R, Irwin H, et al. (2006). Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. Anticancer Drugs 17:155–64
- López-Pérez JL, del Olmo E, de Pascual-Teresa B, et al. (1995). Unambiguous configurational and conformational determination of thuriferic acid. Tetrahedron 51:6343–8
- López-Pérez JL, Therón R, del Olmo E, Díaz D. (2007). NAPROC-13: a database for the dereplication of natural product mixtures in bioassay-guided protocols. Bioinformatics 23:3256–7
- Meresse P, Dechaux E, Monneret C, Bertounesque E. (2004). Etoposide: Discovery and medicinal chemistry. Curr Med Chem 11:2443–66
- Mohamadi F, Richards NGJ, Guida WC, et al. (1990). Macro-model – An integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J Comput Chem 11:440–67
- Moraes RM, Lata H, Bedir E, et al. (2002) The American mayapple and its potential for podophyllotoxin production. In: Janick J, Whipkey A, eds. Trends in New Crops and New Uses. Alexandria, Virginia: ASHS Press, 527–32
- Rassmann I, Thodtmann R, Mross M, et al. (1998). Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion. Invest New Drugs 16:319–24
- Ribeiro RA, Vale ML, Thomazzi SM, et al. (2000). Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 387:111–18
- San Feliciano A, Gordaliza M, Miguel del Corral, JM, et al. (1993). Antineoplastic and antiviral activities of some cyclolignans. Planta Med 59:246–9
- San Feliciano A, López JL, Medarde M, et al. (1988). Thuriferic acid. A novel lignan type from Juniperus thurifera L. Tetrahedron 44:7255–60
- San Feliciano A, Medarde M, Lopez JL, et al. (1989). Lignans from Juniperus thurifera L. Phytochemistry 28:2863–6
- Schacter L. (1996). Etoposide phosphate: What, why, where, and how? Semin Oncol 23:1–7.
- Stahelin H, von Wartburg A. (1989). From podophyllotoxin glucoside to etoposide. Prog Drug Res 33:169–266
- Svensson B, Pettersson H. (2003). Reumacon (CPH82) showed similar X-ray progression and clinical effects as methotrexate in a two years comparative study on patients with early rheumatoid arthritis. Scand J Rheumatol 32:83–8
- Winter CA, Risley EA, Nuss GW. (1962). Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 111:544–7
- You Y. (2005). Podophyllotoxin derivatives: Current synthetic approaches for new anticancer agents. Curr Pharm Des 11:1695–717
- Zakaria ZA, Ghani ZD, Nor RN, et al. (2008). Antinociceptive, anti-inflammatory, and antipyretic properties of an aqueous extract of Dicranopteris linearis leaves in experimental animal models. J Nat Med 62:179–87
- Zimmermann M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109–10